Galapagos reported 155.17M in Operating Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
AstraZeneca AZN:LN 11.54B 4.45B
Biogen BIIB:US $ 1984.9M 304.4M
Genmab GEN:DC 1.42B 235M
Gilead Sciences GILD:US $ 3579M 392M
GlaxoSmithKline GSK:LN 7.14B 722M
GRIFOLS GRF:SM 1.1B 129.52M
H. Lundbeck A/S LUN:DC 3.49B 123M
Hikma Pharmaceutical HIK:LN 873M 27M
Merck MRK:GR 3.93B 105M
Neurocrine Biosciences NBIX:US $ 251.5M 25.4M
Novartis NOVN:VX 10.13B 319M
Vertex Pharmaceuticals VRTX:US $ 929.65M 901.68M
YTE INCY:US $ 577.58M 12.7M